Enzyme Drives Cognitive Decline in Mice, Provides New Target for Alzheimer's

A subtle increase of the PKCα protein produces biochemical, cellular, and cognitive impairments akin to those seen in Alzheimer's disease. The finding provides a potential new target for the treatment of the neurodegenerative disorder.